Lung cancer combined with methotrexate-associated lymphoproliferative disorder: A case report

Atsushi Sekimura; Shun Iwai; Aika Funasaki; Nozomu Motono; Katsuo Usuda; Hidetaka Uramoto

doi:10.1016/j.ijscr.2019.05.033

Lung cancer combined with methotrexate-associated lymphoproliferative disorder: A case report

Int J Surg Case Rep. 2019:59:161-164. doi: 10.1016/j.ijscr.2019.05.033. Epub 2019 May 28.

Authors

Atsushi Sekimura¹, Shun Iwai², Aika Funasaki², Nozomu Motono², Katsuo Usuda², Hidetaka Uramoto²

Affiliations

¹ Department of Thoracic Surgery, Kanazawa Medical University, Japan. Electronic address: a24seki@kanazawa-med.ac.jp.
² Department of Thoracic Surgery, Kanazawa Medical University, Japan.

Abstract

Introduction: Methotrexate (MTX)-associated lymphoproliferative disorder occurs in rheumatoid arthritis patients treated with MTX; however, patients with concomitant pulmonary lesions are rare. We present a case of lung cancer combined with MTX-associated lymphoproliferative disorder for which, for which it was necessary to differentiate these from possible pulmonary metastasis.

Presentation of a case: A 72-year-old man was referred to our hospital for treatment of squamous cell carcinoma in the left upper bronchus. He was receiving oral MTX and prednisolone for rheumatoid arthritis for 15 years. However, chest computed tomography performed 1 week before surgery revealed a 1-cm-sized pulmonary nodule in the right lung. Surgical pulmonary resection of the right lung tumor revealed substantial B-cell lymphoma-type lymphoproliferative disorder. Left upper lobectomy for the squamous cell carcinoma in the left upper bronchus was performed 5 weeks after the first surgery. Chest CT performed 2 weeks after the first surgery revealed a new 1-cm-sized nodule in the lower left lung lobe. However, after discontinuing oral MTX therapy, the new lesion in the left lower lobe disappeared.

Discussion and conclusion: In lung cancer patients treated with MTX for rheumatoid arthritis, MTX-associated lymphoproliferative disorder should be considered as a differential diagnosis.

Keywords: LPD; Lung cancer; Lymphoproliferative disorder; MTX; Methotrexate.